Diabetes Clinical Trials in Boston

Showing 141-160 of 300 trials

Effect of Dairy Consumption on Glycemic Control, Body Weight and Cardiovascular Risk in Patients With Type 2 Diabetes

NCT02895867

This is a randomized prospective clinical study in patients with type 2 diabetes to evaluate the effect of dairy products with full or low fat on glycemic control and cardio-metabolic risk factors in comparison to a regular diet.

Type 2 Diabetes

Joslin Diabetes Center112 participantsStarted May 2016

Boston, Massachusetts, United States

COMPLETED< 1 mile

Effect of Dairy Consumption on Glycemic Control, Body Weight and Cardiovascular Risk Factors

NCT02896140

The aim of this study is to determine the relationship between the percentage of calories from dairy intake and long-term glycemic control and weight maintenance in patients with type 2 diabetes who participate in an intensive lifestyle intervention program. The investigators hypothesize that overweight and obese patients with type 2 diabetes who consume higher percentage of calories from dairy products during intensive lifestyle intervention programs have better glycemic control and maintenance of weight loss as compared to those who consume lower percentage of calories from dairy products.

Diabetes Mellitus, Type 2Obesity

Joslin Diabetes Center51 participantsStarted Apr 2016

Boston, Massachusetts, United States

COMPLETEDPHASE1/PHASE2< 1 mile

Free Fatty Acids and Vascular Function in Subjects With Diabetes

NCT00153179

This study will test the hypothesis that reduction in release of free fatty acids from adipocytes will restore insulin-mediated endothelium-dependent vasodilation and skeletal muscle glucose metabolism in subject with type 2 diabetes.

Type 2 Diabetes Mellitus

Brigham and Women's Hospital40 participantsStarted Sep 2005

Boston, Massachusetts, United States

Effect of Dairy Consumption on Glycemic Control, Body Weight and Cardiovascular Risk in Patients With Type 2 Diabetes

Effect of Dairy Consumption on Glycemic Control, Body Weight and Cardiovascular Risk Factors

Free Fatty Acids and Vascular Function in Subjects With Diabetes

Diabetes Trials in Other Cities

Closed-Loop Insulin Delivery in Children Less Than 7 Years of Age

The Monitoring Study

Study to Compare Efficacy of the MiniMed Paradigm REAL-Time System Vs. MDI in Subjects Naive to Insulin Pump Therapy

International Diabetes Closed Loop (iDCL) Trial: Research Site Training Protocol

Dose-Ranging Study to Evaluate the Glycemic Effects, Safety, and Tolerability of Metformin Delayed Release in Subjects With T2DM

Comparison of the Efficacy and Safety of Two Different Dose Adjustment Regimens for Insulin Degludec/Insulin Aspart in Subjects With Type 2 Diabetes Mellitus Previously Treated With Insulin Glargine

A Study to Compare a New Long-Acting Insulin (LY2605541) and Human Insulin NPH in Participants With Type 2 Diabetes

A Study in Participants With Type 2 Diabetes Mellitus

Exenatide Study of Cardiovascular Event Lowering Trial (EXSCEL): A Trial To Evaluate Cardiovascular Outcomes After Treatment With Exenatide Once Weekly In Patients With Type 2 Diabetes Mellitus

Efficacy and Safety of FIAsp Compared to Insulin Aspart in Combination With Insulin Glargine and Metformin in Adults With Type 2 Diabetes

Pharmacist-led Group Medical Visits to Help With Diabetes Management

Compare Two Dosing Algorithms in Insulin-Naive Patients With Type 2 Diabetes Mellitus

Efficacy and Safety Study of Rosiglitazone/Metformin Therapy vs Rosiglitazone and Metformin in Type 2 Diabetes Subjects

Efficacy and Safety of Toujeo® Versus Tresiba® in Insulin-Naive Patients With Type 2 Diabetes Mellitus Inadequately Controlled With Oral Antihyperglycemic Drug(s) ± GLP-1 Receptor Agonist

AVANDAMET Versus Metformin For Type 2 Diabetes Mellitus

Evaluate the Efficacy and Safety of Insulin Compared to Glargine in Patients With Type 2 Diabetes

Home Testing of Day and Night Closed Loop With Pump Suspend Feature

Other Conditions in Boston